Novago Therapeutics Ag
Clinical trials sponsored by Novago Therapeutics Ag, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A first-in-human (FIH) clinical trial to investigate the human monoclonal antibody NG004, administrated intrathecally in acute spinal cord injury (SCI) patients Results expected Mar 2027 (estimated)